Trexquant Investment LP Alnylam Pharmaceuticals, Inc. Transaction History

Trexquant Investment LP

  • $8.06 Billion
  • Q4 2024

A detailed history of Trexquant Investment LP transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 44,024 shares of ALNY stock, worth $10.4 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
44,024
Previous 90,743 51.48%
Holding current value
$10.4 Million
Previous $25 Million 58.5%
% of portfolio
0.13%
Previous 0.33%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
SELL
$232.27 - $300.43 $10.9 Million - $14 Million
-46,719 Reduced 51.48%
44,024 $10.4 Million
Q3 2024

Nov 12, 2024
BUY
$233.81 - $287.01 $12.4 Million - $15.2 Million
52,880 Added 139.66%
90,743 $25 Million
Q2 2024

Aug 13, 2024
SELL
$143.31 - $247.0 $8.47 Million - $14.6 Million
-59,112 Reduced 60.96%
37,863 $9.2 Million
Q1 2024

May 14, 2024
BUY
$146.51 - $198.2 $6.68 Million - $9.03 Million
45,578 Added 88.68%
96,975 $14.5 Million
Q4 2023

Feb 09, 2024
BUY
$151.41 - $196.57 $6.11 Million - $7.94 Million
40,376 Added 366.36%
51,397 $9.84 Million
Q3 2023

Nov 13, 2023
BUY
$170.77 - $211.65 $1.88 Million - $2.33 Million
11,021 New
11,021 $1.95 Million
Q4 2022

Feb 13, 2023
BUY
$185.53 - $241.31 $104,082 - $135,374
561 Added 1.3%
43,673 $10.4 Million
Q3 2022

Nov 14, 2022
BUY
$138.54 - $232.0 $5.97 Million - $10 Million
43,112 New
43,112 $8.63 Million
Q2 2022

Aug 11, 2022
SELL
$120.42 - $169.29 $2.59 Million - $3.64 Million
-21,496 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$127.18 - $173.91 $2.73 Million - $3.74 Million
21,496 New
21,496 $3.51 Million
Q1 2021

May 13, 2021
SELL
$126.83 - $175.69 $810,824 - $1.12 Million
-6,393 Closed
0 $0
Q4 2020

Feb 11, 2021
BUY
$122.97 - $147.0 $786,147 - $939,771
6,393 New
6,393 $831,000
Q2 2020

Aug 07, 2020
SELL
$104.21 - $156.44 $1.72 Million - $2.58 Million
-16,471 Closed
0 $0
Q1 2020

May 08, 2020
BUY
$93.12 - $133.99 $979,808 - $1.41 Million
10,522 Added 176.87%
16,471 $1.79 Million
Q4 2019

Feb 12, 2020
BUY
$74.51 - $124.23 $15,945 - $26,585
214 Added 3.73%
5,949 $685,000
Q3 2019

Nov 08, 2019
SELL
$70.9 - $87.82 $628,032 - $777,909
-8,858 Reduced 60.7%
5,735 $461,000
Q2 2019

Aug 09, 2019
BUY
$65.86 - $92.79 $297,226 - $418,761
4,513 Added 44.77%
14,593 $1.06 Million
Q1 2019

May 13, 2019
BUY
$72.76 - $93.45 $733,420 - $941,976
10,080 New
10,080 $942,000
Q1 2018

May 03, 2018
SELL
$115.92 - $148.54 $350,194 - $448,739
-3,021 Closed
0 $0
Q4 2017

Feb 09, 2018
BUY
$114.49 - $139.98 $345,874 - $422,879
3,021
3,021 $384,000

Others Institutions Holding ALNY

# of Institutions
667
Shares Held
112M
Call Options Held
839K
Put Options Held
771K
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $29.2B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email